Viewing Study NCT05697705


Ignite Creation Date: 2025-12-25 @ 3:25 AM
Ignite Modification Date: 2026-03-04 @ 10:25 AM
Study NCT ID: NCT05697705
Status: COMPLETED
Last Update Posted: 2024-11-21
First Post: 2023-01-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Effectiveness of the Oxford-AstraZeneca COVID-19 Vaccine as a 2nd Booster, the REFORCO-Brazil Study
Sponsor: AstraZeneca
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module